Inventor · disambiguated record
Jun Xu
Also filed as: XU JUN · XU JUN JOHN
18 granted patents·22 pending applications·50 citations·filing 1998–2024
91Inventor score
Files withOKLAHOMA MED RES FOUND7INTRADIGM CORP5XU JUN4BEIJING TIANTAN HOSPITAL CAPITAL MEDICAL UNIV2SIRNAOMICS BIOPHARMACEUTICALS SUZHOU CO LTD2
Top patents by PatentIndex Score
40 records- 0191US8716218B2Extracellular histones as biomarkers for prognosis and molecular targets for therapyESMON CHARLES T·Filed 2008·Granted May 6, 2014·19 cites·9 claims
- 0289US8153766B2Monoclonal antibodies against activated protein CXU JUN·Filed 2008·Granted Apr 10, 2012·9 cites·9 claims
- 0385US9012622B2Compositions and methods using siRNA molecules and siRNA cocktails for the treatment of breast cancerLU PATRICK Y·Filed 2009·Granted Apr 21, 2015·7 cites·12 claims
- 0484US9127072B2Methods of treating hemophilia using monoclonal antibodies against activated protein CXU JUN·Filed 2011·Granted Sep 8, 2015·5 cites·1 claims
- 0574US10350261B2Extracellular histones as biomarkers for prognosis and molecular targets for therapyOKLAHOMA MED RES FOUND·Filed 2015·Granted Jul 16, 2019·1 cites·23 claims
- 0674US10238711B2Extracellular histones as biomarkers for prognosis and molecular targets for therapyOKLAHOMA MED RES FOUND·Filed 2014·Granted Mar 26, 2019·1 cites·6 claims
- 0770US11028369B2Induced extended pluripotent stem cells, method of making and usingBEIHAO STEM CELL AND REGENERATIVE MEDICINE RES INSTITUTE CO LTD·Filed 2016·Granted Jun 8, 2021·1 cites·5 claims
- 0870US7781414B2Targets for tumor growth inhibitionINTRADIGM CORP·Filed 2004·Granted Aug 24, 2010·2 cites·31 claims
- 0970US2025333728A1Utr molecule for increasing protein expression levelSUZHOU ABOGEN BIOSCIENCES CO LTD·Filed 2023·Application pending·0 cites
- 1069US11458187B2Extracellular histones as biomarkers for prognosis and molecular targets for therapyOKLAHOMA MED RES FOUND·Filed 2019·Granted Oct 4, 2022·0 cites·4 claims
- 1166US2025188422A1Induced totipotent potential stem cells, methods of making and usingUNIV BEIJING·Filed 2023·Application pending·0 cites
- 1265US2025136910A1Devices for use as blood brain barrier modelsMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1363US12144835B2Combination drugs of lachnospiraceae bacteria and human immunoglobulinINST RADIATION MEDICINE CHINESE ACADEMY MEDICAL SCIENCES·Filed 2022·Granted Nov 19, 2024·0 cites·9 claims
- 1463US2024206441A1Method for Constructing Murine Model with Mutations in Csf1r Gene and Application thereofBEIJING TIANTAN HOSPITAL CAPITAL MEDICAL UNIV·Filed 2023·Application pending·0 cites
- 1562US12134773B1Mycovirus-induced gene silencing vector, construction method and application thereofINSTITUTE OF PLANT PROT IPP CHINESE ACADEMY OF AGRICULTURAL SCIENCES CAAS·Filed 2023·Granted Nov 5, 2024·0 cites·6 claims
- 1661US2018092961A1Extracellular histones as biomarkers for prognosis and molecular targets for therapyOKLAHOMA MED RES FOUND·Filed 2017·Application pending·0 cites
- 1760US12186323B2Combination drugs of hypoxanthine and human immunoglobulinINST OF BLOOD TRANSFUSION CHINESE ACADEMY OF MEDICAL SCIENCES·Filed 2022·Granted Jan 7, 2025·0 cites·9 claims
- 1859US2010203036A1Targets for tumor growth inhibitionINTRADIGM CORP·Filed 2009·Application pending·0 cites
- 1958US2025011788A1Nucleic acid interference pharmaceutical composition, and drug for treating colorectal cancer, gastric cancer, and prostate cancerSIRNAOMICS BIOPHARMACEUTICALS SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 2057US2024156966A1A sirna drug, a pharmaceutical composition, a sirna-small molecule drug conjugate, and the application thereofSIRNAOMICS BIOPHARMACEUTICALS SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 2157US2025032476A1Alpha-2a adrenergic receptor modulators and uses thereofUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 2257US2024058445A1Inducible chimeric antigen receptor and application thereofBEIJING TIANTAN HOSPITAL CAPITAL MEDICAL UNIV·Filed 2023·Application pending·0 cites
- 2356US2025263704A1Nucleic acid-polypeptide nano-pharmaceutical compostion for treating and preventing human papilloma virus infectionSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 2454US9944962B2Clone of xiamenmycin biosynthesis gene cluster and heterologous expression thereofUNIV SHANGHAI JIAOTONG·Filed 2014·Granted Apr 17, 2018·0 cites·1 claims
- 2552US2012255599A1Nanocone-based photovoltaic solar cellsXU JUN·Filed 2011·Application pending·0 cites
- 2651US11895994B2Humanized knock-in mouse expressing human Protein CSHANGHAI RAAS BLOOD PRODUCTS CO LTD·Filed 2020·Granted Feb 13, 2024·0 cites·6 claims
- 2749US9091687B2ELISpot diagnostic kit for neuromyelitis optica and its applicationXU JUN·Filed 2013·Granted Jul 28, 2015·0 cites·4 claims
- 2849US2023000916A1Anti-cd3 scfv and cytokine producing artificial antigen presenting cellsUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 2948US2022175926A1Targeted synergistic cancer immunotherapyBRIGHAM & WOMENS HOSPITAL INC·Filed 2020·Application pending·0 cites
- 3048US2025277057A1Monoclonal antibody against human activated protein c and preparation and use thereofOKLAHOMA MED RES FOUND·Filed 2021·Application pending·0 cites
- 3148US2015344588A1Monoclonal antibodies against activated protein cOKLAHOMA MED RES FOUND·Filed 2015·Application pending·0 cites
- 3247US2007219118A1Therapeutic methods for nucleic acid delivery vehiclesINTRADIGM CORP·Filed 2006·Application pending·0 cites
- 3344US9969995B2Methods for recombinant expression of beta-glucosidase geneWILMAR SHANGHAI BIOTECHNOLOGY RES & DEV CT CO LTD·Filed 2015·Granted May 15, 2018·0 cites·16 claims
- 3444US2007154990A1Assays for identifying inhibitors of fatty acid amide hydrolaseWANG YUREN·Filed 2006·Application pending·0 cites
- 3542US2007203082A1RNAI Agents For Anti-SARS Coronavirus TherapyINTRADIGM CORP·Filed 2004·Application pending·0 cites
- 3641US6953568B1Targeting of molecules to large vessel endothelium using EPCROKLAHOMA MED RES FOUND·Filed 1998·Granted Oct 11, 2005·5 cites·21 claims
- 3741US2003138407A1Therapeutic methods for nucleic acid delivery vehiclesFiled 2002·Application pending·0 cites
- 3841US2006211637A1Methods of down regulating target gene expression in vivo by introduction of interfering rnaINTRADIGM CORP·Filed 2003·Application pending·0 cites
- 3934US2005238581A1Dynamic hepatic recycling glucose tolerance testKURLAND IRWIN J·Filed 2005·Application pending·0 cites
- 4030US11613735B2Methods for reprograming non-hepatocyte cells into hepatocyte cellsBEIHAO STEM CELL AND REGENERATIVE MEDICINE TRANSLATIONAL RES INSTITUTE·Filed 2015·Granted Mar 28, 2023·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Jun Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →